Chlorthalidone Compared With HCTZ for MACE Reduction
To compare the clinical benefits of these diuretics, the study authors conducted a literature search that reported on outcomes such as MACE and left ventricular mass.
Hypertension
Latest Health Technology at CES 2021
MPR highlights health innovations from the 2021 Consumer Electronics Show (CES).
NSAID Use Among US Adults With Cardiovascular Disease Examined
Cross-sectional data from the National Health and Nutrition Examination Survey from 1988 to 1994 and 1999 to 2016 were used for this analysis.
USPSTF Finds Evidence Lacking for Child HTN Screening
I statement based on lack of studies examining benefits and harms of screening, impact of treatment on outcomes in adulthood
FDA Identifies Most Needed Meds to Address Urgent Medical Conditions
This action was in response to an executive order issued on August 6, 2020 aimed at protecting the public against outbreaks of emerging diseases and chemical, biological, radiological, and nuclear threats.
Certain HTN Meds May Cut Deaths From Influenza, Pneumonia
Use of ACE-I/ARB vs nonuse linked to lower mortality for those hospitalized with flu, pneumonia.
Real-World Antihypertensive Prescribing Deviates From Guidelines, Study Says
The aim of the study was to analyze antihypertensive utilization patterns among patients with uncontrolled hypertension despite receiving therapy.
Tenapanor Under Review for Hyperphosphatemia in CKD
Tenapanor is a first-in-class oral medication that works by blocking the NHE3 transporter in the gastrointestinal tract.
Antihypertensive Drugs and Cancer Risk: Is There a Link?
Five antihypertensive drug classes were analyzed separately and were also compared to all other treatment groups, including placebo.
Empagliflozin Beneficial in Heart Failure With Reduced Ejection Fraction
In a trial, empagliflozin reduced the risks for heart failure hospitalization and renal outcomes in patients with heart failure with reduced ejection fraction.
